Natural Killer Cells Therapeutics and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Natural Killer Cells Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Natural Killer Cells Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Natural Killer Cells Therapeutics Overall Market Size
2.1 Global Natural Killer Cells Therapeutics Market Size: 2022 VS 2029
2.2 Global Natural Killer Cells Therapeutics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Natural Killer Cells Therapeutics Players in Global Market
3.2 Top Global Natural Killer Cells Therapeutics Companies Ranked by Revenue
3.3 Global Natural Killer Cells Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Natural Killer Cells Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Natural Killer Cells Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Natural Killer Cells Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Natural Killer Cells Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Natural Killer Cells Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Natural Killer Cells Therapeutics Market Size Markets, 2022 & 2029
4.1.2 NK Cell Therapies
4.1.3 NK Cell Directed Antibodies
4.2 By Type - Global Natural Killer Cells Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Natural Killer Cells Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global Natural Killer Cells Therapeutics Revenue, 2024-2029
4.2.3 By Type - Global Natural Killer Cells Therapeutics Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Natural Killer Cells Therapeutics Market Size, 2022 & 2029
5.1.2 Cancer
5.1.3 Gastrointestinal Diseases
5.1.4 Immunoproliferative Disorders
5.1.5 Others
5.2 By Application - Global Natural Killer Cells Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Natural Killer Cells Therapeutics Revenue, 2018-2023
5.2.2 By Application - Global Natural Killer Cells Therapeutics Revenue, 2024-2029
5.2.3 By Application - Global Natural Killer Cells Therapeutics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Natural Killer Cells Therapeutics Market Size, 2022 & 2029
6.2 By Region - Global Natural Killer Cells Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Natural Killer Cells Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global Natural Killer Cells Therapeutics Revenue, 2024-2029
6.2.3 By Region - Global Natural Killer Cells Therapeutics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Natural Killer Cells Therapeutics Revenue, 2018-2029
6.3.2 US Natural Killer Cells Therapeutics Market Size, 2018-2029
6.3.3 Canada Natural Killer Cells Therapeutics Market Size, 2018-2029
6.3.4 Mexico Natural Killer Cells Therapeutics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Natural Killer Cells Therapeutics Revenue, 2018-2029
6.4.2 Germany Natural Killer Cells Therapeutics Market Size, 2018-2029
6.4.3 France Natural Killer Cells Therapeutics Market Size, 2018-2029
6.4.4 U.K. Natural Killer Cells Therapeutics Market Size, 2018-2029
6.4.5 Italy Natural Killer Cells Therapeutics Market Size, 2018-2029
6.4.6 Russia Natural Killer Cells Therapeutics Market Size, 2018-2029
6.4.7 Nordic Countries Natural Killer Cells Therapeutics Market Size, 2018-2029
6.4.8 Benelux Natural Killer Cells Therapeutics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Natural Killer Cells Therapeutics Revenue, 2018-2029
6.5.2 China Natural Killer Cells Therapeutics Market Size, 2018-2029
6.5.3 Japan Natural Killer Cells Therapeutics Market Size, 2018-2029
6.5.4 South Korea Natural Killer Cells Therapeutics Market Size, 2018-2029
6.5.5 Southeast Asia Natural Killer Cells Therapeutics Market Size, 2018-2029
6.5.6 India Natural Killer Cells Therapeutics Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Natural Killer Cells Therapeutics Revenue, 2018-2029
6.6.2 Brazil Natural Killer Cells Therapeutics Market Size, 2018-2029
6.6.3 Argentina Natural Killer Cells Therapeutics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Natural Killer Cells Therapeutics Revenue, 2018-2029
6.7.2 Turkey Natural Killer Cells Therapeutics Market Size, 2018-2029
6.7.3 Israel Natural Killer Cells Therapeutics Market Size, 2018-2029
6.7.4 Saudi Arabia Natural Killer Cells Therapeutics Market Size, 2018-2029
6.7.5 UAE Natural Killer Cells Therapeutics Market Size, 2018-2029
7 Natural Killer Cells Therapeutics Companies Profiles
7.1 Affimed
7.1.1 Affimed Company Summary
7.1.2 Affimed Business Overview
7.1.3 Affimed Natural Killer Cells Therapeutics Major Product Offerings
7.1.4 Affimed Natural Killer Cells Therapeutics Revenue in Global Market (2018-2023)
7.1.5 Affimed Key News & Latest Developments
7.2 Celgene
7.2.1 Celgene Company Summary
7.2.2 Celgene Business Overview
7.2.3 Celgene Natural Killer Cells Therapeutics Major Product Offerings
7.2.4 Celgene Natural Killer Cells Therapeutics Revenue in Global Market (2018-2023)
7.2.5 Celgene Key News & Latest Developments
7.3 Fate Therapeutics
7.3.1 Fate Therapeutics Company Summary
7.3.2 Fate Therapeutics Business Overview
7.3.3 Fate Therapeutics Natural Killer Cells Therapeutics Major Product Offerings
7.3.4 Fate Therapeutics Natural Killer Cells Therapeutics Revenue in Global Market (2018-2023)
7.3.5 Fate Therapeutics Key News & Latest Developments
7.4 Fortress Biotech
7.4.1 Fortress Biotech Company Summary
7.4.2 Fortress Biotech Business Overview
7.4.3 Fortress Biotech Natural Killer Cells Therapeutics Major Product Offerings
7.4.4 Fortress Biotech Natural Killer Cells Therapeutics Revenue in Global Market (2018-2023)
7.4.5 Fortress Biotech Key News & Latest Developments
7.5 Glycostem Therapeutics
7.5.1 Glycostem Therapeutics Company Summary
7.5.2 Glycostem Therapeutics Business Overview
7.5.3 Glycostem Therapeutics Natural Killer Cells Therapeutics Major Product Offerings
7.5.4 Glycostem Therapeutics Natural Killer Cells Therapeutics Revenue in Global Market (2018-2023)
7.5.5 Glycostem Therapeutics Key News & Latest Developments
7.6 Innate Pharma
7.6.1 Innate Pharma Company Summary
7.6.2 Innate Pharma Business Overview
7.6.3 Innate Pharma Natural Killer Cells Therapeutics Major Product Offerings
7.6.4 Innate Pharma Natural Killer Cells Therapeutics Revenue in Global Market (2018-2023)
7.6.5 Innate Pharma Key News & Latest Developments
7.7 Nantkwest
7.7.1 Nantkwest Company Summary
7.7.2 Nantkwest Business Overview
7.7.3 Nantkwest Natural Killer Cells Therapeutics Major Product Offerings
7.7.4 Nantkwest Natural Killer Cells Therapeutics Revenue in Global Market (2018-2023)
7.7.5 Nantkwest Key News & Latest Developments
7.8 Nkarta Therapeutics
7.8.1 Nkarta Therapeutics Company Summary
7.8.2 Nkarta Therapeutics Business Overview
7.8.3 Nkarta Therapeutics Natural Killer Cells Therapeutics Major Product Offerings
7.8.4 Nkarta Therapeutics Natural Killer Cells Therapeutics Revenue in Global Market (2018-2023)
7.8.5 Nkarta Therapeutics Key News & Latest Developments
7.9 NKT Therapeutics
7.9.1 NKT Therapeutics Company Summary
7.9.2 NKT Therapeutics Business Overview
7.9.3 NKT Therapeutics Natural Killer Cells Therapeutics Major Product Offerings
7.9.4 NKT Therapeutics Natural Killer Cells Therapeutics Revenue in Global Market (2018-2023)
7.9.5 NKT Therapeutics Key News & Latest Developments
7.10 Ziopharm Oncology
7.10.1 Ziopharm Oncology Company Summary
7.10.2 Ziopharm Oncology Business Overview
7.10.3 Ziopharm Oncology Natural Killer Cells Therapeutics Major Product Offerings
7.10.4 Ziopharm Oncology Natural Killer Cells Therapeutics Revenue in Global Market (2018-2023)
7.10.5 Ziopharm Oncology Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Natural Killer Cells Therapeutics Market Opportunities & Trends in Global Market
Table 2. Natural Killer Cells Therapeutics Market Drivers in Global Market
Table 3. Natural Killer Cells Therapeutics Market Restraints in Global Market
Table 4. Key Players of Natural Killer Cells Therapeutics in Global Market
Table 5. Top Natural Killer Cells Therapeutics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Natural Killer Cells Therapeutics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Natural Killer Cells Therapeutics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Natural Killer Cells Therapeutics Product Type
Table 9. List of Global Tier 1 Natural Killer Cells Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Natural Killer Cells Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Natural Killer Cells Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Natural Killer Cells Therapeutics Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Natural Killer Cells Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Natural Killer Cells Therapeutics Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Natural Killer Cells Therapeutics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Natural Killer Cells Therapeutics Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2024-2029
Table 30. Affimed Company Summary
Table 31. Affimed Natural Killer Cells Therapeutics Product Offerings
Table 32. Affimed Natural Killer Cells Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 33. Affimed Key News & Latest Developments
Table 34. Celgene Company Summary
Table 35. Celgene Natural Killer Cells Therapeutics Product Offerings
Table 36. Celgene Natural Killer Cells Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 37. Celgene Key News & Latest Developments
Table 38. Fate Therapeutics Company Summary
Table 39. Fate Therapeutics Natural Killer Cells Therapeutics Product Offerings
Table 40. Fate Therapeutics Natural Killer Cells Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 41. Fate Therapeutics Key News & Latest Developments
Table 42. Fortress Biotech Company Summary
Table 43. Fortress Biotech Natural Killer Cells Therapeutics Product Offerings
Table 44. Fortress Biotech Natural Killer Cells Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 45. Fortress Biotech Key News & Latest Developments
Table 46. Glycostem Therapeutics Company Summary
Table 47. Glycostem Therapeutics Natural Killer Cells Therapeutics Product Offerings
Table 48. Glycostem Therapeutics Natural Killer Cells Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 49. Glycostem Therapeutics Key News & Latest Developments
Table 50. Innate Pharma Company Summary
Table 51. Innate Pharma Natural Killer Cells Therapeutics Product Offerings
Table 52. Innate Pharma Natural Killer Cells Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 53. Innate Pharma Key News & Latest Developments
Table 54. Nantkwest Company Summary
Table 55. Nantkwest Natural Killer Cells Therapeutics Product Offerings
Table 56. Nantkwest Natural Killer Cells Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 57. Nantkwest Key News & Latest Developments
Table 58. Nkarta Therapeutics Company Summary
Table 59. Nkarta Therapeutics Natural Killer Cells Therapeutics Product Offerings
Table 60. Nkarta Therapeutics Natural Killer Cells Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 61. Nkarta Therapeutics Key News & Latest Developments
Table 62. NKT Therapeutics Company Summary
Table 63. NKT Therapeutics Natural Killer Cells Therapeutics Product Offerings
Table 64. NKT Therapeutics Natural Killer Cells Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 65. NKT Therapeutics Key News & Latest Developments
Table 66. Ziopharm Oncology Company Summary
Table 67. Ziopharm Oncology Natural Killer Cells Therapeutics Product Offerings
Table 68. Ziopharm Oncology Natural Killer Cells Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 69. Ziopharm Oncology Key News & Latest Developments
List of Figures
Figure 1. Natural Killer Cells Therapeutics Segment by Type in 2022
Figure 2. Natural Killer Cells Therapeutics Segment by Application in 2022
Figure 3. Global Natural Killer Cells Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Natural Killer Cells Therapeutics Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Natural Killer Cells Therapeutics Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Natural Killer Cells Therapeutics Revenue in 2022
Figure 8. By Type - Global Natural Killer Cells Therapeutics Revenue Market Share, 2018-2029
Figure 9. By Application - Global Natural Killer Cells Therapeutics Revenue Market Share, 2018-2029
Figure 10. By Type - Global Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Natural Killer Cells Therapeutics Revenue Market Share, 2018-2029
Figure 12. By Application - Global Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Natural Killer Cells Therapeutics Revenue Market Share, 2018-2029
Figure 14. By Region - Global Natural Killer Cells Therapeutics Revenue Market Share, 2018-2029
Figure 15. By Country - North America Natural Killer Cells Therapeutics Revenue Market Share, 2018-2029
Figure 16. US Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Natural Killer Cells Therapeutics Revenue Market Share, 2018-2029
Figure 20. Germany Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 21. France Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Natural Killer Cells Therapeutics Revenue Market Share, 2018-2029
Figure 28. China Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 32. India Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Natural Killer Cells Therapeutics Revenue Market Share, 2018-2029
Figure 34. Brazil Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Natural Killer Cells Therapeutics Revenue Market Share, 2018-2029
Figure 37. Turkey Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 41. Affimed Natural Killer Cells Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Celgene Natural Killer Cells Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Fate Therapeutics Natural Killer Cells Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Fortress Biotech Natural Killer Cells Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Glycostem Therapeutics Natural Killer Cells Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Innate Pharma Natural Killer Cells Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Nantkwest Natural Killer Cells Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Nkarta Therapeutics Natural Killer Cells Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. NKT Therapeutics Natural Killer Cells Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Ziopharm Oncology Natural Killer Cells Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Industry Market Size
